This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

12 May 2019

Catalent achieves global ISO accreditation

Company is one of the first CDMOs to receive award.

Catalent has announced that the British Standards Institute (BSI) has awarded Catalent a global accreditation against the international management standards for environment (ISO14001:2015) and occupational safety (OHSAS18001:2007). The accreditation, for Catalent’s global Environment, Health & Safety (EHS) management system is one of the first to be awarded in the pharmaceutical industry to a CDMO.

BSI’s auditors judged that Catalent’s EHS system demonstrates a high degree of sophistication and maturity, and competes at a world-class performance level with other leading industries and businesses.

“Our EHS system drives our core values of injury prevention and environmental sustainability, and is central to supporting customer and patient expectations,” commented Mark Incledion, Catalent’s Global Director, EHS. He added: “This accreditation is very much in line with Catalent's patient-first and corporate responsibility-driven philosophy, while helping us meet our environmental targets and promote a cleaner planet.”

Catalent’s global network of facilities produce over 70 billion doses annually and are approved by 35 regulatory agencies to provide flexible commercial and clinical manufacturing supplies in oral, sterile, biologic and inhaled dose forms for customers around the world.

Mentioned Companies
Catalent Pharma Solutions
View company profile

Related News